CSPC Pharmaceutical Group (CSPCY) Insider Trading & Ownership C$2.42 +0.02 (+0.83%) (As of 12/20/2024 05:55 PM ET) Add Compare Share Share Insider Trades Stock AnalysisChartDividendInsider TradesShort Interest There is no recent insider trading on record for CSPC Pharmaceutical Group, but the stock has been recently traded by U.S. Congress members, who may have more information about the industry than the general public. Get CSPCY Insider Trade Alerts Want to know when executives and insiders are buying or selling CSPC Pharmaceutical Group stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Ad DTICackling Kamala hates this companyDo you want to see one of the most exciting election trades of all time? A trade that could help America become 100% energy independent… Reduce energy costs to virtually zero… And hand investors what could be a stunning return in just a few years’ time? It all has to do with a little known company that is helping to kick off the next great American energy revolution. Before that happens, you need to see the details here. CSPC Pharmaceutical Group Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellAverage Share PriceTotal Transaction9/15/2023Josh GottheimerU.S. Congress Member (D-NJ)Sell$2.94$1,001 - $15,0007/14/2023Josh GottheimerU.S. Congress Member (D-NJ)Buy$3.20$1,001 - $15,0006/13/2023Josh GottheimerU.S. Congress Member (D-NJ)Sell$3.34$1,001 - $15,00012/30/2022Josh GottheimerU.S. Congress Member (D-NJ)Sell$4.08$1,001 - $15,0004/19/2022Josh GottheimerU.S. Congress Member (D-NJ)Buy$1,001 - $15,0003/15/2022Josh GottheimerU.S. Congress Member (D-NJ)Sell$1,001 - $15,0001/10/2022Josh GottheimerU.S. Congress Member (D-NJ)Buy$1,001 - $15,000 (Data available from 1/1/2013 forward) CSPC Pharmaceutical Group Key ExecutivesMr. Dongchen Cai (Age 70)Executive Chairman Compensation: $2.61MMr. Cuilong Zhang (Age 55)Vice-Chairman & CEO Compensation: $1.39MMr. Chunlei Li (Age 48)Executive Director & Chief Scientist Compensation: $943.49kMr. Kin Man Chak (Age 58)Executive Director Compensation: $690.29kMr. Weidong Pan (Age 55)Executive Director Compensation: $501.46kMr. Huaiyu Wang (Age 61)Executive Director Compensation: $616.37kMr. Zhenguo Wang (Age 54)Executive Director Compensation: $499.06kDr. Qingxi Wang Ph.D. (Age 58)Executive Director Compensation: $435.55kDr. Hao Jiang (Age 40)Executive Director Compensation: $374.86kMr. Tai On Lo CPA (Age 70)Company Secretary More Insider Trading Tools from MarketBeat Related Companies Roche Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (OTCMKTS:CSPCY) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CSPC Pharmaceutical Group Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share CSPC Pharmaceutical Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CSPCY Stock Alerts